Drug-eluting balloon versus second-generation drug-eluting stent for the treatment of restenotic lesions involving coronary bifurcations

Toru Naganuma, Azeem Latib, Charis Costopoulos, Jacopo Oreglia, Luca Testa, Federico De Marco, Alessandro Candreva, Alaide Chieffo, Charbel Naim, Matteo Montorfano, Francesco Bedogni, Antonio Colombo

Research output: Contribution to journalArticlepeer-review

Abstract

Aims: To report clinical outcomes in patients treated with drug-eluting balloon (DEB) versus second-generation drug-eluting stent (DES) for in-stent restenosis (ISR) involving a bifurcation lesion. Methods and results: Between February 2007 and November 2012, 167 bifurcation restenoses in 158 patients were treated with either DEB (n=73) or second-generation DES (n=85). The EuroSCORE was significantly higher in the DEB group (4.2±3.8 vs. 2.8±2.1, p=0.004). Regarding restenosed stent type, second- generation DES was more frequently seen in the DEB group (26.9% vs. 6.7%, p

Original languageEnglish
Pages (from-to)989-995
Number of pages7
JournalEuroIntervention
Volume11
Issue number9
DOIs
Publication statusPublished - Jan 1 2016

Keywords

  • Coronary bifurcation
  • Drug-eluting balloon
  • In-stent restenosis
  • Second-generation drug-eluting stent

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Drug-eluting balloon versus second-generation drug-eluting stent for the treatment of restenotic lesions involving coronary bifurcations'. Together they form a unique fingerprint.

Cite this